Posted by bearfan on January 31, 2011, at 16:38:00
In reply to Re: Vilazodone Marketing » bearfan, posted by ed_uk2010 on January 31, 2011, at 16:09:17
No, its more of there not being much data with head to head studies. Viibryd was only compared to Citalopram (Celexa) and Placebo. All released data seems to point to high tolerability, but not a whole lot on efficacy other than the HAM-D. I think Viibryd may be more of a trade-off drug; much in the way of Lexapro. It may have much lower side profile, but the efficacy seems to be rather unproven until its released and we have some real life testimony.
poster:bearfan
thread:977653
URL: http://www.dr-bob.org/babble/20110130/msgs/978411.html